Last Posted: Apr 11, 2020
- Comparative ACE2 variation and primate COVID-19 risk
AD Melin et al, BIORXIV, April 11, 2020 - Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance.
Engel Christoph et al. International journal of cancer 2020 146(4) 999-1009 - Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
Tung Nadine M et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Apr JCO2000299 - Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.
Torrorey-Sawe Rispah et al. Frontiers in genetics 2020 11170 - Summary report of the 2019 Diversity and Inclusion Task Force of the National Society of Genetic Counselors.
Channaoui Nadine et al. Journal of genetic counseling 2020 Apr 29(2) 192-201 - [Hereditary breast carcinomas pathologist's perspective].
Vincent-Salomon Anne et al. Annales de pathologie 2020 Mar - Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'.
De Falco Vincenzo et al. ESMO open 2020 Mar 5(2) - Hunt Is on for Genetic Clues to Why Coronavirus Impact Varies
AD Marcus, WSJ, April 7, 2020 - New Machine Learning Applications to Accelerate Personalized Medicine in Breast Cancer: Rise of the Support Vector Machines.
Ozer Mustafa Erhan et al. Omics : a journal of integrative biology 2020 Mar - Positive Correlation Between Somatic Mutations in RAS Gene and Colorectal Cancer in Telangana Population: Hospital-Based Study in a Cosmopolitan City.
Goud Kalal Iravathy et al. Applied biochemistry and biotechnology 2020 Feb 190(2) 703-711
.png)
No hay comentarios:
Publicar un comentario